Abirakast 500 mg Tablet
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Abirakast 500 mg Tablet contains abiraterone acetate, an androgen biosynthesis (CYP17) inhibitor. Its labelling describes it for the treatment of prostate gland cancer, and the doctor may also prescribe it for other medical conditions as they see fit, or in combination with other drugs as part of chemotherapy. It is described as blocking the action of hormones responsible for the growth of cancer cells in the prostate gland, thereby slowing or stopping disease progression.
Product Information
The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the treatment of prostate gland cancer
- Described as also prescribed for other medical conditions as the doctor sees fit
- Described as blocking the action of hormones responsible for the growth of prostate cancer cells, slowing or stopping disease progression
Described Dosage & Administration
- The dose and directions are decided by the doctor
- May be prescribed in combination with other drugs as part of chemotherapy
- Swallowed whole on an empty stomach, in line with the guidance for this medicine
Described Side Effects
The product description does not list specific side effects. Effects reported for abiraterone acetate include:
- Swelling (edema)
- Decreased potassium level in the blood
- High blood pressure
- Fatigue
- Vomiting or diarrhoea
Any common temporary side effect that persists should be reported to the doctor immediately.
Precautions
- Medical records should be shared with the healthcare team to avoid wrong medicine pairing
- Any persistent side effect should be reported to the doctor immediately
- Liver function, blood pressure, and blood potassium may be monitored during treatment with this medicine
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains abiraterone acetate and is used for the treatment of prostate gland cancer, and for other conditions as the doctor sees fit. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as blocking the action of hormones responsible for the growth of cancer cells in the prostate gland, slowing or stopping disease progression.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.